Abstract Purpose:Trefoil factor family (TFF) peptides are thought to contribute to epithelial protection and restitution by virtue of their protease-resistant nature and their strong affinity for mucins. However, they are often overexpressed in tumors, where they seem to be negative prognostic factors, possibly contributing to tumor spread, although the precise mechanisms have not been defined. Experimental Design:Tissue sections from 111patients with curatively resected advanced gastric carcinoma were immunohistochemically stained forTFF2, ITF (TFF3), and CD34. Microvessel density was expressed as number and area of microvessels. Results were correlated with clinicopathological characteristics and patient survival. Results: Forty-nine (44.1%) and 41 (36.9%) tumors were immunohistochemically positive for TFF3 and TFF2, respectively. Among the various clinicopathologic variables, overexpression of TFF3 had a significant correlation with patient age only. In addition, a significantly higher prevalence of positive TFF2 staining was detected in large, diffuse tumors and in tumors with lymph node metastasis. The number of microvessels had a significant correlation with both TFF3 and TFF2 staining, whereas the area of microvessels had a significant correlation only with TFF3 staining. Both TFF3 and TFF2 were independent predictors of a worse disease-free survival. TFF3 had a gender-specific negative survival advantage, with a 91.3% disease-free survival in female patients with TFF3-negative advanced gastric carcinoma. Conclusions: Induction of increased tumor vascularity might be one of the mechanisms by which TFFs confer metastatic phenotype and frequent disease recurrence in gastric carcinomas. Female patients with TFF3-negative advanced gastric carcinoma have comparable survival as that reported for patients with early gastric carcinoma.
It is well established that the integrity of the gastrointestinal mucosa and other epithelium are maintained by a number of secreted factors, but recent studies suggest that one important mechanism involves the secretion of the members of a protease-resistant protein family known as the trefoil factor family (TFF; ref. 1) . Trefoil proteins are characterized by the presence of at least one 40 -amino acid protein domain with three conserved disulfide bonds, a domain that has been labeled as the trefoil motif. TFFs are typically secreted with mucus and as such contribute to the barrier film that often coats surface epithelial cells. In addition, TFFs are often rapidly up-regulated in the setting of mucosal damage or injury, where they contribute to epithelial restitution (2) . Whereas the healing properties of TFFs were initially attributed to the effects of cellular proliferation, it was later established that the effect was primarily due to promotion of cellular motility/ migration and possibly to inhibition of apoptosis (3 -5) . In any case, the luminal activity and stability of trefoil peptides make these proteins attractive candidates for the treatment of gastrointestinal disease, such as inflammatory bowel disease and radiochemotherapy-induced intestinal damage (6 -8) .
In addition to a role in restitution and healing, TFFs have also been linked to the development of neoplasia. The role of TFFs in tumorigenesis remains elusive; in general, TFF1 seems to function as a gastric-specific tumor suppressor gene, whereas TFF2 and TFF3 have been thought to augment tumor progression by increasing cellular invasion and metastasis (9, 10) . TFF2 is frequently up-regulated in gastric preneoplastic lesions (11) and microarray analysis of gastric cancers has revealed alterations in TFF gene expression (12 -14) . Although the mechanisms are not understood, expression of TFFs is often dysregulated in cells during the progression to invasive cancer (15 -17) . Recently, we showed that the overexpression of TFF2 is common in gastric carcinoma and is often associated with cancer invasion, metastasis, and a poor prognosis (18) . Similarly, Yamachika et al. (17) reported that patients with TFF3/ITF-positive gastric carcinomas also show invasive characteristics and a poor prognosis. To date, a number of mecha-nisms have been proposed to account for the invasive nature of TFF-expressing tumors, including the activation of several growth-promoting genes and the inhibition of apoptosis-related pathways. In an earlier study, we speculated that the invasive phenotype of TFF2-expressing tumors might be related to the induction of the neovascularization (18) . Interestingly, Rodrigues et al. (19) recently provided concrete evidence for the induction of angiogenesis by the TFFs in an in vitro study. However, no clinical correlation has, as yet, been shown between the overexpression of TFFs and angiogenesis. Therefore, in this study, we investigated the possibility of a relationship between TFF2 and TFF3 expression and angiogenesis in primary gastric carcinoma specimens.
Materials and Methods
Patients and samples. Between February 1990 and December 1998, 111 patients with advanced gastric cancer undergoing curative resection were included in this study. Of these patients, 39 were female and 72 were male; their ages ranged from 32 to 94 years. Routinely, all tumors and lymph nodes were cut at several levels, embedded in paraffin, and sections were taken for routine H&E staining. A group of experienced pathologists in the Central Pathological Laboratory checked all of these slides and documented the pathologic characteristics of the tumor and lymph nodes. Tumor stage was defined according to the tumor, node, and metastasis (TNM 2002) staging system. Histologic classification was done according to the Lauren classification. The follow-up was complete in all patients. The data obtained at regular follow-up visits at the outpatient department were prospectively stored in a database specially designed for gastric carcinoma patients. An update inquiry about the present status of all surviving patients was made by telephone call in March 2004. In case of any recurrence, the exact date of disease recurrence was collected from the referring physician or from the physician who attended the patient the first time for the diagnosis of the disease recurrence. All patients provided consent for use of tumor tissue for clinical research and the University Ethical Committee approved the research protocol.
Immunohistochemistry. All sections used in this study contained grossly normal-appearing, noncancerous gastric mucosa (in most cases, with intestinal metaplasia or spasmolytic protein-expressing metaplasia) and tumor tissue. For each patient, we selected one representative paraffin block, which contained mostly tumor tissue and a small amount of adjacent normal gastric mucosa. The normal mucosa areas were always adjacent to the tumor tissue, and were approximately within 0.5 to 1.5 cm of the invasive front. Briefly, slides were deparaffinized, rehydrated in graded alcohols, and placed in PBS solution. Antigen retrieval was done by autoclaving the slides for 10 minutes in citrate buffer (pH 6.0; Dako ChemMate, Dako, Denmark) for TFF2 and TFF3 staining. Endogenous peroxidase activity was quenched by dipping in 3% H 2 O 2 for 30 minutes. Nonspecific binding was blocked by treating slides with normal serum from the species in which secondary antibody was developed for 30 minutes. Slides were treated with mouse anti-human TFF2 monoclonal antibody (GE16C clone, Novocastra Laboratories Ltd., Newcastle, United Kingdom, 1:50 dilution), Rabbit polyclonal anti-TFF3 antibody (HM89, a generous gift from Dr. Daniel K. Podolsky, Massachusetts General Hospital, Boston, MA) overnight at 4jC and with mouse anti-CD34 antibody for 1 hour at room temperature. The streptavidin-biotin peroxidase complex method was employed for the immunohistochemical steps and was done with a commercially available kit (Histofine SAB-PO kit, Nichirei, Tokyo, Japan) as we described previously (20) . Color development was done with the peroxidase substrate 3-amino-9-ethylcarbazole. Adjacent normal mucosa served as an internal positive control, and in negative control slides, the primary antibody was replaced by nonimmune serum of the same species in which the primary antibody was raised. Counterstaining was done with hematoxylin in TFF2 and TFF3 staining, however, it was omitted in CD34 staining to facilitate subsequent image analysis.
Evaluation of immunohistochemical staining. Evaluation of all immunohistochemical staining was done blindly and independently by two of the authors (D.K. Dhar and Y. Tonomoto). Any discordant finding between the two observers was settled by using a conference microscope. The evaluation criteria of TFF2 in gastric carcinoma were described in detail in our previously published article (20) . TFF2 was stained uniformly in positive cases and there was no staining at all in negative cases. Tumors having cytoplasmic or both cytoplasmic and membranous staining were considered to be positive for TFF2. On the other hand, there were wide variations in intensity and extent of TFF3 staining among the tumors and were evaluated according to a comprehensive scoring formula described previously (21) . Briefly, the intensity of staining was scored as follows: 1, weak expression; 2, moderate expression; and 3, strong expression. The extent of staining was scored as 1, <33% of the tumor cells had positive staining; 2, 33% to 67% of the tumor cells had positive staining and; 3, >67% tumor cells had positive staining. The results obtained with the two scales of staining score were multiplied against each other, yielding a single scale with scores of 1, 2, 3, 4, 6, and 9. Patients having a TFF3 staining score of >4 were considered to be positive for TFF3.
Evaluation of angiogenesis. Tumor angiogenesis was evaluated in two formats, number of microvessels (nMVD) and cross-sectional area of microvessels (aMVD). In nMVD, the most vascular area of the tumor (hotspot) was identified under low magnification (Â40) and later, the number of microvessels stained by CD34 was counted at higher magnification in at least five highly vascular fields. Any cluster of endothelial cells with or without any lumen was considered as a microvessel. In the aMVD method, the whole tumor was scanned at low (Â40) magnification under a light microscope and five of the most vascular areas were selected (Â200). Digital images were captured by using a charge-coupled device video camera (HC-300/OL, Olympus, Tokyo, Japan) and a color image freezer computer software (Photograb-300 SH-3, Fuji Film, Tokyo, Japan), and stored on optical discs. Quantification of the CD34-stained area was done by a public domain NIH Image program (developed at the U.S. NIH and available on the Internet at http://rsb.info.nih.gov/nih-image/) on a Macintosh computer. Low frequency background was removed with the ''background subtraction'' tool and the area of the stained vessels was measured as the number of pixels per unit area of the tumor (2.8 million pixels).
Statistical analysis. The correlation between TFF expression and various clinicopathologic variables was determined by the Fisher's exact test or Mann-Whitney U test as appropriate. The correlation between two continuous variables was examined by Sperman's rank test. The survival curves were plotted using the Kaplan-Meier method and the statistical significance between groups was determined by the log rank test. The end points for analysis were the disease-free survival and the overall survival starting from the day of operation. Independent variables predicting survival were evaluated by the multivariable analysis using the Cox proportional hazard model. The Statview 4.5J (Abacus Concepts, Berkley, CA) software was used for data analysis.
Results
TFF3 and TFF2 immunohistochemistry. There was no moderate and marked background staining for TFF3, however, consistent staining was noticed in the smooth muscle layer of the stomach. Intestinal metaplastic epithelium adjacent to the tumor was always positive for TFF3, and occasionally, mucosal cells in the lower half of the fundic glands were positive for TFF3. Tumor staining was heterogeneous and staining of TFF3 was mostly noticed in the cytoplasm (Fig. 1A) and occasionally in the cell membrane and nucleus (Fig. 1B) . In two cases, tumor tissues inside metastatic lymph nodes and blood vessels adjacent to the primary tumor specimen were strongly positive for TFF3 (Fig. 1C) . Strong staining in the infiltrating cells, most probably macrophages, was noticed but the lymphoid follicles and lymphocytes were negative for TFF3 staining (Fig. 1D) . Also, vascular endothelial cells were strongly positive for TFF3 (Fig. 1C) .
In contrast to TFF3 staining, intestinal metaplastic mucosa was always negative for TFF2, whereas consistent staining for TFF2 was noticed in gastric mucosal cells with abundant mucous granules and in those having morphologic similarity with both antral glands and Brunner's gland of the duodenum (also known as spasmolytic protein-expressing metaplasia; data not shown). Weak membranous staining was the characteristic feature for most of the intestinal types of tumors, whereas strong cytoplasmic staining was observed in diffuse types of tumors (Fig. 2B) . TFF2 staining was occasionally noticed in vascular endothelial cells. However, there was no staining observed in the interstitial infiltrating cells and in the lymphocytes. Strong immunoreactivity for both TFF3 and TFF2 was noticed in the vicinity of highly vascularized tumor areas as shown in Fig. 2 . A stronger staining was noticed in the vascular endothelial cells by anti-TFF3 (Fig. 1C) than by anti-TFF2 antibody.
TFF3 and TFF2 reactivity and correlation with clinicopathologic features. Among the 111 patients with advanced gastric carcinoma, 49 (44.1%) patients were positive for TFF3 and 62 (55.9%) patients were negative. The average age of TFF3-positive patients was significantly higher (P = 0.0174, MannWhitney U test) than those with TFF3-negative tumors (mean F SD, 67.88 F 11.76 versus 63.40 F 10.86, respectively). There was no significant correlation with gender, tumor location, differentiation status and T stage. Only a trend of higher prevalence of TFF3 positivity was noticed in larger tumors (mean F SD, 6.38 F 2.90 versus 5.52 F 2.94; P = 0.0954) and in lymph node -positive cases (P = 0.0934); however, a statistical significance could not be reached (Table 1) . Positivity of interstitial cells for TFF3 had no impact on any of the clinicopathologic factors evaluated in this study (data not shown).
Forty-one (36.9%) tumors were positive for TFF2 and 70 (63.1%) were negative. There was a strong correlation with tumor differentiation status and higher prevalence of TFF2 positivity in diffuse types of tumors (P = 0.0023). A significantly high (P = 0085) prevalence of TFF2 positivity was noticed when the tumors were located in the body and antrum of the stomach. The average tumor size of TFF2-positive tumors (mean F SD, 6.97 F 3.55 versus 5.27 F 2.32) was significantly higher (P = 0.0195) than those of negative ones. Prevalence of expression of TFF2 was significantly (P = 0.0470) higher in patients with lymph node metastasis than in those with no lymph node metastasis (Table 2) . . According to Spearman's rank correlation test, there was a significant correlation (P = 0.0016, r = 30.6) between the nMVD and aMVD (data not shown). As shown in Table 1 , the averages of both nMVD (P = 0.0079, F test and P = 0.1470, Mann-Whitney U test) and aMVD (P = 0.0280, Mann-Whitney U test) were significantly higher in TFF3-positive tumors than in TFF3-negative tumors. Whereas, the average of only nMVD was significantly high in TFF2-positive tumors but aMVD had no correlation with TFF2 positivity (Table 2) . According to Spearman's correlation test, TFF3 had significant correlation with both nMVD (P = 0.0224) and aMVD (P = 0.0172); however, TFF2 had significant correlation only with nMVD (P = 0.0228; data not shown). (Â40) . B, occasionally, strong staining in both cytoplasmic and nuclear compartments was observed. Also endothelial cells lining the blood vessels were positively stained for TFF3 (Â100). Arrows, nuclear staining. C, metastatic gastric carcinoma tissue inside the metastatic lymph nodes and blood vessels adjacent to the primary tumor was strongly stained forTFF3 (Â10). Arrows, vascular invasion by tumor cells. D, infiltrating cells, most likely macrophages, were strongly stained for TFF3 (Â40; inset, Â400). Arrows inside the inset, TFF3-stained interstitial cells.
Survival analysis and multivariable analysis of prognostic factors. TFF3 expression had a significant impact on diseasefree survival (P = 0.0013; Fig. 3A) but not on overall survival (P = 0.0855; Fig. 3B ). However, when the survival analysis was repeated separately in male and female patients, TFF3 overexpression had significant impact on both disease-free survival (P = 0.0029; Fig. 3C ) and overall survival (P = 0.0213; Fig. 3D ) only in female patients. A similar significant impact of TFF3 expression was not found in male patients (data not shown). The 5-year disease-free survival in female patients with TFF3-negative tumors was 91.3%, whereas it was only 42.8% in patients with TFF3-positive tumors. TFF2 had a significant Abbreviations: nMVD, number of microvessel density; aMVD, area of microvessel density. impact only on disease-free survival (P = 0.0030, and P = 0.3745 on overall survival) where patients with TFF2 overexpression had frequent disease recurrences. A gender-specific survival advantage for TFF2 negativity could not be detected (data not shown).
The median values of nMVD and aMVD were used to dichotomize patients into high and low angiogenic profiles. The disease-free survival was significantly longer (P = 0.0393) in patients with low aMVD in comparison with those with high aMVD. Whereas, nMVD had no significant survival benefit either in terms of disease-free survival or overall survival. Only when the cut-off point for nMVD was set at 95 was there a significant difference (P = 0.0308) in the disease-free survival (data not shown). Therefore, in the multivariable analysis, only aMVD was included as a covariate.
Conventional prognostic factors along with TFF3 expression, TFF2 expression, and aMVD entered the multivariable analysis for the disease-free survival. Union Internationale Contra Cancrum tumor stage had the highest hazard ratio for disease recurrence and strongest prognostic impact (hazard ratio = 3.19 and P < 0.0001). Both TFF3 and TFF2 became independent prognostic factors in the multivariable analysis, however, the TFF3 expression (hazard ratio = 3.05 and P = 0.0090) had superior predictability of the disease recurrence than TFF2 (hazard ratio = 2.30 and P = 0.0489; Table 3 ).
Discussion
Although TFFs exhibit a number of beneficial effects in cytoprotection and restitution, they may have adverse consequences when overexpressed in tumors. Previous studies have suggested the possible effects of trefoils on proliferation, apoptosis, motility, and invasion. In this study, we present data that TFFs may also contribute to tumorigenesis through promotion of angiogenesis. Both TFF2 and TFF3 expression was detectable in vascular endothelial cells. Whereas the number of microvessels correlated with TFF2 and TFF3, only TFF3 Abbreviations: nMVD, number of microvessel density; aMVD, area of microvessel density. correlated with the total area of microvessels, suggesting that the angiogenic property of TFF3 was greater than that of TFF2. Finally, overexpression of TFF2 and TFF3 had a significant negative impact on patient survival after curative resection of advanced gastric carcinoma, and in a multivariable analysis along with the tumor, node, and metastasis stage was an independent predictor of disease recurrence. TFF3 has previously been suggested by Yamachika et al. (17) to represent a poor prognostic factor in patients with gastric carcinoma. Our results confirm this earlier finding that in a multivariable analysis, TFF3 expression represents, after the tumor, node, and metastasis stage, the second highest risk for disease recurrence following surgical resection. Nevertheless, our results differed in several important respects from this earlier study. In contrast with the Yamachika study, which showed that TFF3 expression had no survival impact in females but significantly impacted survival in male patients, we found that TFF3 expression was a strong predictor of survival in female patients. Indeed, in our study, female patients with advanced gastric carcinoma that were TFF3-negative exhibited a 91.3% 5-year survival, comparable to patients with early gastric cancers. The reason for the stronger female preference for TFF3's clinical associations is not entirely clear, although direct evidence for estrogen-mediated TFF3 expression was reported by May and Westley (21) . In this study, the authors showed that estradiol treatment increased TFF3 mRNA expression by 3-to 10-fold, and that up-regulated TFF3 gene expression could also be induced by tamoxifen. Direct evidence for differences in the overall level of TFF3 expression between men and women is lacking, and although a few studies have suggested that tamoxifen, in combination with other agents, may have some therapeutic role in the treatment of gastric cancer (22 -24) .
Although the reason for the negative impact of TFF3 expression is not entirely clear, circumstantial evidence in this study supports a role for angiogenesis. Tumor angiogenesis is a coordinated process that involves the migration of endothelial progenitors into a region of hypoxia where exposure to angiogenic growth factors leads to the generation of new blood vessels (25) . At present, it is not clear as to the mechanism by which TFFs are able to promote tumor angiogenesis, although a number of previous studies have suggested that TFFs can stimulate migration of intestinal epithelial cells and possibly tumor cells as well. Recently, studies by Rodrigues et al. (19) showed in an in vitro model that TFFs could stimulate angiogenesis in a manner comparable to vascular endothelial growth factor; the angiogenic activity of TFF3 was dose-dependent and could be blocked by epidermal growth factor receptor (ZD1839) and cyclooxygenase-2 (NS-3998) inhibitors. Given these data, it seems likely that TFFs contribute directly to angiogenesis, although further studies will be required to show that this is a direct effect. An alternative possibility is that hypoxia, which has been shown to induce TFF3 transcription through hypoxia-inducible factor-1a, could lead to increased angiogenesis and increased TFF3 expression (26) . Indeed, a recent report by Zhang et al. (27) showed that immature rats suffering from hypoxia-induced necrotizing enterocolitis could be rescued by recombinant TFF3 treatment.
Although expression of both TFF2 and TFF3 showed a significant positive correlation with tumor angiogenesis and a negative correlation with patient survival, the two trefoil factors differed in several important respects. As noted previously, TFF2 was not expressed in intestinal metaplasia, strongly expressed in spasmolytic protein-expressing metaplasia, and overexpressed in tumors with a diffuse histology, large tumors and tumors with frequent lymph node metastasis. In contrast, TFF3 was consistently expressed in intestinal metaplasia, occasionally in spasmolytic protein-expressing metaplasia, was overexpressed in elderly patients, but had no significant correlation with histology, tumor size, or metastases. In diffuse gastric cancers, TFF2 was preferentially expressed in cancer cells invading into the muscularis mucosa and beyond, whereas TFF3 staining had no such characteristic feature and was more uniformly expressed in cancer tissue.
In conclusion, the results of this study show that expression of TFF2 and TFF3 in gastric cancer could be associated with patient survival after a curative resection and were independent predictors of disease recurrence. Expression of TFF2 and TFF3 in gastric cancer seemed to correlate with tumor MVD in gastric carcinoma samples, suggesting a possible role in tumor angiogenesis. Further studies are needed to more precisely define the role of trefoil peptide expression in gastric cancer. 
